Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | +7.74% | +6.03% | +3.73% |
01:31pm | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
08/03 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 12.81M 1.07B | Sales 2025 * | 46.35M 3.87B | Capitalization | 220M 18.32B |
---|---|---|---|---|---|
Net income 2024 * | -51M -4.26B | Net income 2025 * | -23M -1.92B | EV / Sales 2024 * | 17.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.74 x |
P/E ratio 2024 * |
-4.4
x | P/E ratio 2025 * |
-10.7
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.03% |
Latest transcript on Ovid Therapeutics Inc.
1 day | +7.74% | ||
1 week | +6.03% | ||
Current month | +9.51% | ||
1 month | +8.09% | ||
3 months | -13.02% | ||
6 months | -4.71% | ||
Current year | +3.73% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01/14/01 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 01/19/01 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 28/23/28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 14/17/14 |
Bart Friedman
BRD | Director/Board Member | 79 | 23/15/23 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 01/14/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 3.34 | +7.74% | 311 343 |
26/24/26 | 3.1 | +3.68% | 80,529 |
25/24/25 | 2.99 | -5.08% | 112,117 |
24/24/24 | 3.15 | -1.56% | 113,127 |
23/24/23 | 3.2 | +1.59% | 110,579 |
Delayed Quote Nasdaq, April 30, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.73% | 220M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- OVID Stock